MYC and breast carcinoma: Additionally, the finding strengthens the anti-tumor potential of d-limonene suggesting its use as a chemotherapeutic and chemo-preventive drug in the treatment of breast cancer, particularly in tumors associated with Cyclin B1 and c-Myc over expression.